The Windows 11 beta update allows EU users to customize Lock Screen widgets freely This feature is solely available in the EU ...

Other Alzheimer's treatments in development that are set for key data readouts this year, including full phase 2/3 results of Anavex Life Sciences' (AVXL) blarcamesine, phase 2 results on Roche ...

SAN FRANCSCO – Feb. 18, 2025 – CEA-Leti, in its collaboration with Quobly, CEA-List and CEA-Irig, reported today it has developed a solution using FD-SOI CMOS technology that provides simultaneous, ...

The treatment landscape of Inflammatory Bowel Disease (IBD) has undergone a significant transformation over the past two ...

CEA-Leti, in its collaboration with Quobly, CEA-List and CEA-Irig, reported today it has developed a unique solution using FD ...

Exelixis’ next-generation tyrosine kinase inhibitor zanzalintinib is being tested for colorectal cancer, renal cell carcinoma ...

2 new ACLF clinical trials expected to initiate in 1Q25 3 clinical data readouts expected by year-end 2025 across the ACLF pipeline, including on-going UNVEIL-IT® Phase 2 trial Data of on-going ...